Cordis Acquires MedAlliance
October 17, 2022
Cordis, the interventional cardiovascular device company, announced the acquisition of Switzerland-based MedAlliance, developer of the SELUTION SLR sirolimus drug‑eluting balloon. The deal includes an initial $35M investment, $200M payable at closing (expected 2023), plus up to $125M in regulatory milestones and up to $775M in commercial milestones through 2029; Cordis will begin co-promotion of SELUTION SLR in markets where it is available.
- Buyers
- Cordis
- Targets
- MedAlliance
- Industry
- Medical Devices
- Location
- Vaud, Switzerland
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Hellman & Friedman Acquires Cordis from Cardinal Health
August 2, 2021
Medical Devices
Hellman & Friedman has completed the acquisition of Cardinal Health’s Cordis business for approximately $1 billion, with the buyer assuming certain liabilities and Cardinal Health retaining certain working capital accounts. Ajax Health and Zeus Health are partnering with H&F on the transaction; Cordis will operate as an independent medical device company headquartered in Miami Lakes, Florida.
-
Centauri Health Solutions Acquires MedAllies
April 24, 2025
Healthcare Services
Centauri Health Solutions, a Phoenix-based health information technology company, has acquired MedAllies, a New York-based Health Information Service Provider (HISP) and Qualified Health Information Network (QHIN). The deal expands Centauri's clinical exchange network by adding MedAllies' connectivity, messaging and record-location capabilities and brings access to more than 1,000 hospitals, 5,000 ambulatory organizations and 125,000 healthcare providers.
-
Medeologix Acquires Mediballoon, MedeonBio and Second Source Medical
November 28, 2022
Medical Devices
Medeologix, a Taiwan-based MedTech CDMO, acquired three Silicon Valley contract manufacturers — Mediballoon, MedeonBio and Second Source Medical — to create an integrated end-to-end medical device development and manufacturing group. The combined organization brings together tubing extrusion, balloon forming, catheter processing, assembly, packaging and regulatory support, and links U.S. development centers with Medeologix's mass-production facility in Taiwan to support scale-up and commercialization.
-
Cosentus Acquires AllianceMed and MedCloud
October 12, 2023
Healthcare Services
Cosentus has acquired AllianceMed and its subsidiary MedCloud Software Solutions; financial terms were not disclosed. AllianceMed provides in-network and out-of-network billing for ASCs, DME companies, and physician groups, while MedCloud offers billing software, an ASC-focused EMR, and DME management technology; Cosentus plans to invest in the platform and develop AI capabilities to expand its tech-enabled services for independent physician groups and facilities.
-
Biocomposites Acquires Remaining Shares in Laboratorios SL S.A. and Synergie Ingénierie Médicale S.A.R.L.
September 18, 2024
Medical Devices
Biocomposites has acquired the remaining shares in Laboratorios SL S.A. and Synergie Ingénierie Médicale S.A.R.L., gaining full control of the SYNICEM™ and Subiton antibiotic bone cement and preformed spacer product ranges. The deal consolidates Biocomposites' capabilities in infection-management bone cements and spacers and will allow the company to leverage its global distribution network to expand these products' reach.
-
Haemonetics Acquires Cardiva Medical
January 20, 2021
Medical Devices
Haemonetics Corporation agreed to acquire Cardiva Medical, Inc., a privately-held maker of vascular closure systems based in Santa Clara, California, for $475 million upfront and up to $35 million in contingent consideration. The acquisition expands Haemonetics' hospital portfolio and its presence in the interventional cardiology and electrophysiology markets and is expected to be accretive to revenue growth.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.